by Raynovich Rod | Mar 25, 2018 | Biopharmaceuticals, Macro
Sell-Off Gets Scary–NASDAQ Futures Still Down at 1:30A EDT 3/28 Double Bottom -Double Top on XBI and Testing February Lows at $87 Another Sell-Off=Tuesday Movers 3/27/18 Large Caps % Up-NONE FBT Down 3.23%, IBB Down 2.77% to $105.12, QQQ down 3.24%, XBI down...
by Raynovich Rod | Mar 20, 2018 | Biopharmaceuticals
Update-2…3/22 ABBV News Kills Momentum of Biotech Stocks 12:30P EDT Abbvie (ABBV) down 13.5 % on disappointing results on blood cancer drug. The big issue is that the drug was recently acquired for $5.8B from Stemcentrx back in 2016. The Company will not seek...
by Raynovich Rod | Mar 19, 2018 | Biopharmaceuticals, Macro
Update-1… 3/19. Close is off the lows for Biotech Indices QQQ gap down to $167.10 also at SMA 50 XBI at SMA 50 bottom of channel at $91.89 XLV at $84 approaching February lows of $81 It is very difficult to find news or trends that can help us navigate this...
by Raynovich Rod | Mar 14, 2018 | Biopharmaceuticals
Update-1 …March 18- Market jittery on potential global trade war, rising interest rate concerns and political risk. Also Sales to U.S. retailers fell 0.1% in February a 3 month slide. Biotechs are in a risk-off mode with a weak tape. Dow down 0.47%, NASDAQ down...
by Raynovich Rod | Mar 6, 2018 | Biopharmaceuticals
Update-1 March 10… Broad Rally Continues Through The Week QQQ Up 4.3% IBB up 4.3% XBI up 4.8% Gene Editing Stocks Surge Biotech stocks soared along with the market as fear about interest rates, tariffs and global politics subsided helped considerably by economic...
by Raynovich Rod | Feb 28, 2018 | 2025 Rayno Biopharmaceuticals Portfolio
Update after close 2/28/18 Tape deteriorates at last hour of trading, a familiar pattern: IBB down 1.83%, QQQ down 0.64%, XBI down 1.88% for day. Biotechs still up YTD with XBI;FBT down 2.35% but still up 8.28% YTD. Celgene, Inc (CELG) sell-off continues down 9% to...
by Raynovich Rod | Feb 20, 2018 | Biopharmaceuticals
Large Cap Biopharmaceuticals: Winners and Losers, Takeaways Here is a brief analysis from data below. Data Sources : Google Finance and FinViz.com. Our Top Picks continue to do well: Abbvie (ABBV), Bristol-Myers Squibb (BMY) and Gilead Sciences (GILD). Laggards in our...
by Raynovich Rod | Feb 14, 2018 | Biopharmaceuticals
Update-1 …2/17/18 Good Week for Biotech: FBT up 6.29%, IBB up 4.44%, XBI up 6.26% Biotech stocks continued their strong recovery from the big sell-off in the prior week but about 3% under 2018 highs. Biotech ETFs tracked the QQQ up 5.68% for the week but biotech...
by Raynovich Rod | Feb 12, 2018 | Biopharmaceuticals
Large Cap Biopharmaceuticals Performance Part 1- After Correction Technicals: we are holding the December 2017 bottom but 2018 gains on some indices have been wiped out with peak values on Jan. 26. The FBT was the top performing ETF in 2018 YTD. Many of our picks have...
by Raynovich Rod | Feb 4, 2018 | Biopharmaceuticals
Updates-2… 2/6/18 Biotechs Down With Overall Market Over 5 Days Closing Prices as of 2/6/18 XBI up 3% at $91.05 down 5.34% over 5 days IBB up 2% at $109.36 down 7.35% over 5 days QQQ up 2.65% at $162.31 down 5.04% over 5 days By now you have read about all the...